| Literature DB >> 22950052 |
Cleo L Crunelle, Dick J Veltman, Jan Booij, Katelijne Emmerik-van Oortmerssen, Wim van den Brink.
Abstract
Stimulant dependence is associated with neuropsychological impairments. Here, we summarize and integrate the existing neuroimaging literature on the neural substrates of neuropsychological (dys)function in stimulant dependence, including cocaine, (meth-)amphetamine, ecstasy and nicotine dependence, and excessive caffeine use, comparing stimulant abusers (SAs) to nondrug using healthy controls (HCs). Despite some inconsistencies, most studies indicated altered brain activation in prefrontal cortex (PFC) and insula in response to reward and punishment, and higher limbic and anterior cingulate cortex (ACC)/PFC activation during craving and attentional bias paradigms in SAs compared with HCs. Impulsivity in SAs was associated with lower ACC and presupplementary motor area activity compared with HCs, and related to both ventral (amygdala, ventrolateral PFC, insula) and dorsal (dorsolateral PFC, dorsal ACC, posterior parietal cortex) systems. Decision making in SAs was associated with low dorsolateral PFC activity and high orbitofrontal activity. Finally, executive function in SAs was associated with lower activation in frontotemporal regions and higher activation in premotor cortex compared with HCs. It is concluded that the lower activations compared with HCs are likely to reflect the neural substrate of impaired neurocognitive functions, whereas higher activations in SAs compared with HCs are likely to reflect compensatory cognitive control mechanisms to keep behavioral task performance to a similar level as in HCs. However, before final conclusions can be drawn, additional research is needed using neuroimaging in SAs and HCs using larger and more homogeneous samples as well as more comparable task paradigms, study designs, and statistical analyses.Entities:
Keywords: Addiction; fMRI; functional imaging; magnetic resonance imaging; stimulant dependence; stimulants
Year: 2012 PMID: 22950052 PMCID: PMC3432971 DOI: 10.1002/brb3.65
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Overview of the selected reviewed studies on reward and punishment processing in stimulant abusers versus healthy controls
| de Ruiter et al. ( | Goldstein et al. ( | |
|---|---|---|
| Technique | fMRI | fMRI |
| Task | PRLT | monetary reward |
| Abused drug | Nicotine | Cocaine |
| Drug use (SD) | – | 17.6 years (6.7 years) |
| Time since abstinence | Current users | 1–90 days |
| Sample size – users (% male) | 19 (100%) | 16 (75%) |
| Sample size – HCs (% male) | 19 (100%) | 13 (70%) |
| Behavioral findings (vs. HCs) | ↓ Accuracy/gains | ↓ Accuracy/gains |
| = RT | = RT | |
| Response during gains (vs. HCs) | ↑ PFC | ↓ OFC |
| ↑ Insula | ↓ Cerebellum | |
| ↑ Parietal regions | ||
| Response during losses (vs. HCs) | ↓ VL PFC | – |
fMRI, functional magnetic resonance imaging; PRLT, probabilistic reversal learning task; SD, standard deviation; HC, healthy control; RT, reaction time; VL PFC, ventrolateral prefrontal cortex; OFC, orbitofrontal cortex.
Overview of the selected reviewed articles on decision making and executive control
| Decision making | Memory | Flexibility, attention, and planning | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| de Ruiter et al. ( | ||||||||||
| Technique | [15O] PET | [15O] PET | fMRI | fMRI | fMRI | fMRI | fMRI | fMRI | fMRI | fMRI |
| Task | IGT | CambrRT | 2-CPT | N-back | N-back | N-back | N-back | Switch task | PRLT/ToL | SAT |
| Abused drug | Cocaine | Amphetamine | MA | Ecstasy | Ecstasy | Ecstasy | Cocaine | Cocaine | Nicotine | Cocaine |
| Mean drug use | >2 years | 16 years | 17 years | 53/16 month | >2 years | <2 years | 11.7 years | 2.5–18 years | Unknown | 17.6 years |
| Time since last use | 25 days | Current users | 6–46 days | 89/330 days | 23 days | Unknown | >4–5 days | 0–3 days | 10 h | 0–90 days |
| Sample – users (% male) | 13 (77%) | 15 (73%) | 14 (100%) | 8 (50%) | 6 (33%) | 15 (100%) | 8 (unknown) | 19 (100%) | 16 (75%) | |
| Sample – HCs (% male) | 13 (77%) | 15 (73%) | 14 (71%) | 11 (73%) | 8 (50%) | 6 (33%) | 15 (100%) | 8 (unknown) | 19 (100%) | 12 (67%) |
| Performance (vs. HCs) | ↓ | = | = | = | = | = | = | = | ↓/= | = |
| Task response (vs. HCs) | ↑ OFC | ↓ DL PFC | ↑ OFC | ↑ Parietal | ↑ Premotor | ↑ HippoC | ↓ Parietal | ↓ Cingulated | ↓ ACC | |
| ↑ Putamen | ↑ OFC | ↑ DL PFC | ↓ Frontal | ↓ Temporal | ↓ Frontal | ↓ VL PFC | ↓ DL PFC | |||
| ↑ PCG | ↑ Parietal | ↓ Temporal | ↓ Thalamus | ↓ Premotor | ↓ VM PFC | |||||
| ↓ DL PFC | ↓ ACC | ↓ Putamen | ↑ Insula | ↓ Frontal | ||||||
| ↓ m PFC | ↓ Precuneus | ↑ Frontal | Gyrus | |||||||
| ↓ Parietal | Operculum | ↓ Cerebellum | ||||||||
| ↓ Cerebellum | ↓ (Pre)cuneus | |||||||||
| ↓ Parietal | ↓ Thalamus | |||||||||
fMRI, functional magnetic resonance imaging; PET, positron emission tomography; IGT, Iowa Gambling Task; CambrRT, Cambridge Risk Task; 2-CPT, 2-choice prediction task; PRLT, probabilistic reversal learning task; ToL, Tower of London; SAT, sustained attention task; MA, methamphetamine; HC, healthy controls; OFC, orbitofrontal cortex; PCG, postcentral gyrus; (DL/VL/m/VM) PFC, (dorsolateral/ventrolateral/medial/ventromedial) prefrontal cortex; HippoC, hippocampus.
Overview of the selected reviewed studies using cue-reactivity paradigms in stimulant abusers versus healthy control subjects
| Okuyemi et al. (2009) | Goldstein et al. ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Technique | fMRI | [15O] PET | fMRI | fMRI | fMRI | fMRI | fMRI | fMRI | fMRI | fMRI |
| CR stimulus type | Audiovisual | Audiovisual | Audiovisual | Audiovisual | Visual | Visual | Visual | Verbal | Visual | Audiovisual |
| Abused drug | Cocaine | Cocaine | Cocaine | Cocaine | Nicotine | Nicotine | Nicotine | Cocaine | Nicotine | Cocaine |
| Mean drug use | >6 months | 8.1 years | 11 years | Unknown | Unknown | Unknown | 19 years | 16.5 years | Unknown | Chronic |
| Time since last use | Unknown | 13.5 days | Unknown | >14.9 days | >12 h | >12 h | 25 min | 4.6 days | 16–18 h | >3 days |
| Sample – users, | 6 (100%) | 14 (100%) | 17 (82%) | 11 (73%) | 11 (64%) | 9 (44%) | 17 (35%) | 17 (76%) | 18 (100%) | 14 |
| Sample – HCs, | 6 (100%) | 6 (100%) | 14 (36%) | 21 (38%) | 6 (67%) | 11 (27%) | 17 (29%) | 17 (82%) | 17 (100%) | 16 (Matched) |
| CR craving (vs. prescan) | ↑ | ↑ | ↑ | ↑ | ↑ | = | Unknown | ↑ | = | ↑ |
| CR questionnaire | VAS | 10 items | Likert scale | VAS | 3 items | 5 items | QSU-brief | 5 items | QSU | CCQ |
| CR response (vs. HCs) | FTND > 5 | |||||||||
| ↑ ACC | ↑ ACC | ↑ Prefrontal | ↑ ACC | ↑ Amygdala | ↑ NcA | ↑ VL PFC | ↓ ACC | ↑ r ACC | ↑ DLPFC | |
| ↑ DL PFC | ↑ Amygdala | ↑ Insula | ↓ Prefrontal | ↑ Hippocampus | ↑ m PFC | ↑ m PFC | ↑ Occipital | |||
| ↓ Caudate | ↑ Cingulate | ↓ Temporal | ↑ VTA | ↑ OFC | ↑ Insula | |||||
| ↑ Thalamus | AA > CC | ↑ Temporal | ||||||||
| ↑ IPS | ↑ Amygdala | |||||||||
| ↑ Frontal gyrus | ↑ Caudate |
fMRI, functional magnetic resonance imaging; PET, positron emission tomography; CR, cue-reactivity; HC, healthy control; VAS, visual analog scale; QSU, questionnaire for smoking urges; CCQ, cocaine craving questionnaire; FTND, Fagerström test for nicotine dependence; AA, Afro-American; CC, Caucasian; (r) ACC, (rostral) anterior cingulated cortex; (DL/VL/m) PFC, (dorsolateral/ventrolateral/medial) prefrontal cortex; VTA, ventral tegmental area; IPS, intraparietal sulcus; NcA, nucleus accumbens; OFC, orbitofrontal cortex.
Overview of the selected reviewed articles on motor and cognitive impulsivity in substance abusers compared to nondrug using control participants
| Motor impulsivity | Cognitive impulsivity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Technique | fMRI | fMRI | fMRI | [15O] PET | fMRI | fMRI | fMRI | fMRI | fMRI |
| Task | Go/No-go | Go/No-go | Stop-Signal | STROOP | Finger-tapping | Finger-tapping | DD | DD | DD |
| Abused drug | Cocaine | Cocaine | Cocaine | Cocaine | Cocaine | MDMA | MA | MA | Cocaine |
| Mean drug use | 11.2 years | 14 years | 10.2 years | >2 years | 16.3 years | Unknown | >1 year | >1 year | 20.3 years |
| Time since last use (SD) | 18–72 h | 12–72 h | >2 weeks | 23 days | 9–30 h | 669 days (665) | Current users | 2–8 weeks | Current users |
| Sample – users (% male) | 13 (62%) | 15 (60%) | 15 (100%) | 13 (unknown) | 14 (57%) | 14 (71%) | 12 (67%) | 19 (68%) | 15 (73%) |
| Sample – HCs (% male) | 14 (29%) | 15 (47%) | 15 (100%) | 13 (unknown) | 14 (57%) | 10 (50%) | 17 (71%) | 17 (71%) | 11 (81%) |
| Performance (vs. HCs) | ↓ | ↓ | = | = | ↓ | = | ↑ DD | ↑ DD | ↑ DD (ns) |
| Response (vs. HCs) | ↓ DL PFC | ↓ ACC | ↓ rACC | ↓ Left ACC | ↓ Caudate | ↑ SMA | ↓ DL PFC | ↓ Caudate | ↓ PFC |
| ↓ ACC | ↓ Pre-SMA | ↓ PFC | ↓ Putamen | ↓ IPS | ↓ Precuneus | ↓ ACC | |||
| ↓ Parietal | ↓ PFC | ↑ Right ACC | ↓ ACC | ||||||
| ↓ Putamen | ↓ DL PFC | ||||||||
| ↓ Pre-SMA | |||||||||
| ↓ Insula | |||||||||
fMRI, functional magnetic resonance imaging; PET, positron emission tomography; DD, delayed discounting; MA, methamphetamine; SD, standard deviation; HC, healthy control; (r)ACC, (rostral) anterior cingulated cortex; (DL) PFC, (dorsolateral) prefrontal cortex; IPS, intraparietal sulcus; SMA, supplementary motor area.
Brain responses during inhibitory trials; ns, nonsignificant.